MEGAN HILL: Open Payments
NPI 1861791550 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 30 payments from 19 companies in 2025. Trend: 2023 $1,069 · 2024 $1,017 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $151 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| Sumitomo Pharma America, Inc. | 3 | $80 |
| Dendreon Pharmaceuticals LLC | 2 | $57 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| Eisai Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $51 |
| Exelixis Inc. | 1 | $47 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
Products named: OSTEOCOOL RF ABLATION SYSTEM, ORGOVYX, PROVENGE, KEYTRUDA, Lenvima, ELAHERE, KISQALI, CABOMETYX.
Industry payments across CO — which companies pay providers there.
